Sanara MedTech Inc.
SMTINasdaqCIK 714256HealthcareFiscal year ends Dec 31
Reports and events: 271 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-26-049275 |
| 2026-10-1609:20 ET | 8-K | 8.01 Other events | 0001213900-26-110053 |
| 2026-10-0119:48 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001213900-26-105390 |
| 2026-08-1117:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037176 |
| 2026-08-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037131 |
| 2026-08-1116:05 ET | 8-K/A | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037112 |
| 2026-07-2916:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035196 |
| 2026-06-0916:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-027936 |
| 2026-06-0416:15 ET | 8-K | 1.02 Termination of a material agreement | 0001493152-26-027274 |
| 2026-05-1216:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022479 |
| 2026-05-1117:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022291 |
| 2026-04-1707:30 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001493152-26-017156 |
| 2026-03-2416:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-012352 |
| 2026-03-2407:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012266 |
| 2026-03-0216:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008547 |
| 2026-01-2307:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-003316 |
| 2025-11-2616:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-025152 |
| 2025-11-1216:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021894 |
| 2025-11-1207:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021715 |
| 2025-11-1206:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021615 |
| 2025-09-0216:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-012560 |
| 2025-08-1309:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011885 |
| 2025-08-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011878 |
| 2025-05-2808:15 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-012607 |
| 2025-05-2316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001641172-25-012267 |
| 2025-05-1416:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010254 |
| 2025-05-1407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-010097 |
| 2025-04-2216:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005713 |
| 2025-04-2116:15 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-005554 |
| 2025-04-0416:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002780 |
| 2025-03-2517:23 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000632 |
| 2025-03-2507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000506 |
| 2025-01-2216:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-003236 |
| 2025-01-2216:21 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003234 |
| 2025-01-2116:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-003043 |
| 2024-12-0407:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-048602 |
| 2024-11-1217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044829 |
| 2024-11-1216:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044737 |
| 2024-10-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-040275 |
| 2024-09-2316:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-037820 |
| 2024-09-1116:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-035783 |
| 2024-08-1216:44 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031301 |
| 2024-08-1216:02 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031254 |
| 2024-06-2009:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-024438 |
| 2024-06-1816:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-024275 |
| 2024-06-1717:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024163 |
| 2024-05-3016:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-24-021982 |
| 2024-05-1316:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-018880 |
| 2024-05-1309:20 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-018808 |
| 2024-04-1809:20 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-015133 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.